Hannemann, C.; Brettschneider, A.; van Dijck, P.; Stangl, K.; Ludwig, A.; Hewing, B.
Deficiency of Inactive Rhomboid Protein 2 (iRhom2) Attenuates Macrophage Atherogenicity. Biology 2026, 15, 860.
https://doi.org/10.3390/biology15110860
AMA Style
Hannemann C, Brettschneider A, van Dijck P, Stangl K, Ludwig A, Hewing B.
Deficiency of Inactive Rhomboid Protein 2 (iRhom2) Attenuates Macrophage Atherogenicity. Biology. 2026; 15(11):860.
https://doi.org/10.3390/biology15110860
Chicago/Turabian Style
Hannemann, Carmen, Alica Brettschneider, Phillip van Dijck, Karl Stangl, Antje Ludwig, and Bernd Hewing.
2026. "Deficiency of Inactive Rhomboid Protein 2 (iRhom2) Attenuates Macrophage Atherogenicity" Biology 15, no. 11: 860.
https://doi.org/10.3390/biology15110860
APA Style
Hannemann, C., Brettschneider, A., van Dijck, P., Stangl, K., Ludwig, A., & Hewing, B.
(2026). Deficiency of Inactive Rhomboid Protein 2 (iRhom2) Attenuates Macrophage Atherogenicity. Biology, 15(11), 860.
https://doi.org/10.3390/biology15110860